UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003135
Receipt No. R000003741
Scientific Title Randomized phase II study of bortezomib plus dexamethasone (BD) versus thalidomide plus dexamethasone (TD) for relapsed or refractory multiple myeloma (JCOG0904, r II BD vs TD for MM)
Date of disclosure of the study information 2010/02/03
Last modified on 2014/10/24 17:24:06

No. Disposal Last modified on Item of update
1 Insert 2010/02/03 13:34:30
2 Update 2011/08/03 12:26:06 Name of person sending information
Name of person sending information
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2011/08/03 12:31:15
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
4 Update 2012/05/28 15:41:21 Institutions
5 Update 2012/06/20 11:39:28 Acronym
Acronym
6 Update 2012/10/22 13:29:42 Institutions
7 Update 2014/08/20 11:50:38 Key inclusion criteria
Key inclusion criteria
Target sample size
8 Update 2014/08/20 11:52:43 Division name
Division name
TEL
Email
Division name
Division name
TEL
Institutions
9 Update 2014/08/20 11:53:46 Anticipated trial start date
Last follow-up date
10 Update 2014/10/24 17:24:06 Recruitment status


Contact us.